Olympus introduced the FDA-cleared EZ Shot 3 Plus single use aspiration needle.
EndoChoice stock declined 6.36 percent in short interest.
The European Commission approved the Swiss-based Novartis drug Afinitor for advanced gastrointestinal and lung neuroendocrine tumor treatment.
SpectraScience completed training for the first group of physicians using the WavSTAT4 Optical Biopsy SystemR in Barcelona, Spain.
More articles on GI/endoscopy:
Olympus introduces new single use aspiration needle: 4 notes
Unsafe injection practices lead to HCV outbreak, clinic closure: 4 insights
4 key points on Mercy Health-Fairfield Hospital’s $14M plan to improve inpatient & outpatient endoscopy services
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
